These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6154706)
1. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein. Kerbiriou DM; Bouma BN; Griffin JH J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706 [TBL] [Abstract][Full Text] [Related]
2. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains. Bock PE; Shore JD; Tans G; Griffin JH J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090 [TBL] [Abstract][Full Text] [Related]
3. Isolation and functional properties of the heavy and light chains of human plasma kallikrein. van der Graaf F; Tans G; Bouma BN; Griffin JH J Biol Chem; 1982 Dec; 257(23):14300-5. PubMed ID: 6815193 [TBL] [Abstract][Full Text] [Related]
4. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. Mori K; Nagasawa S J Biochem; 1981 May; 89(5):1465-73. PubMed ID: 6168636 [TBL] [Abstract][Full Text] [Related]
5. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. Kerbiriou DM; Griffin JH J Biol Chem; 1979 Dec; 254(23):12020-7. PubMed ID: 500690 [TBL] [Abstract][Full Text] [Related]
6. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation. Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191 [No Abstract] [Full Text] [Related]
7. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. Hock J; Vogel R; Linke RP; Müller-Esterl W J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851 [TBL] [Abstract][Full Text] [Related]
8. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen. Nakayasu T; Nagasawa S J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988 [TBL] [Abstract][Full Text] [Related]
9. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. Scott CF; Colman RW J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688 [TBL] [Abstract][Full Text] [Related]
10. Rat plasma high-molecular-weight kininogen. A simple method for purification and its characterization. Hayashi I; Kato H; Iwanaga S; Oh-ishi S J Biol Chem; 1985 May; 260(10):6115-23. PubMed ID: 3846594 [TBL] [Abstract][Full Text] [Related]
11. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions. Olson ST; Francis AM; Sheffer R; Choay J Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292 [TBL] [Abstract][Full Text] [Related]
12. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Thompson RE; Mandle R; Kaplan AP Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905 [TBL] [Abstract][Full Text] [Related]
13. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. Mandle R; Kaplan AP J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348 [TBL] [Abstract][Full Text] [Related]
14. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. Wiggins RC J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057 [TBL] [Abstract][Full Text] [Related]
15. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein. Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861 [TBL] [Abstract][Full Text] [Related]
16. Limited proteolysis of human low-molecular-mass kininogen by tissue kallikrein. Isolation and characterization of the heavy and the light chains. Müller-Esterl W; Rauth G; Lottspeich F; Kellermann J; Henschen A Eur J Biochem; 1985 May; 149(1):15-22. PubMed ID: 2581778 [TBL] [Abstract][Full Text] [Related]
17. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta. Hermann A; Buchinger P; Somlev B; Rehbock J Placenta; 1996 May; 17(4):223-30. PubMed ID: 8761966 [TBL] [Abstract][Full Text] [Related]
18. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4. Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705 [TBL] [Abstract][Full Text] [Related]
19. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. Schapira M; Scott CF; Colman RW Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423 [TBL] [Abstract][Full Text] [Related]
20. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity. Tait JF; Fujikawa K J Biol Chem; 1986 Nov; 261(33):15396-401. PubMed ID: 3096985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]